Absence of Dendritic Reticulum Cell Staining Is Helpful for Distinguishing T-Cell-Rich B-Cell Lymphoma From Lymphocyte Predominance Hodgkin's Disease

[1]  L. Leder,et al.  HOW TO DIFFERENTIATE BETWEEN T‐CELL‐RICH B‐CELL LYMPHOMA AND LYMPHOCYTE‐PREDOMINANT HODGKIN'S DISEASE. EVIDENCE FOR THE VALUE OF MB1 AND 4KB5 IMMUNOSTAINING , 1996, The Journal of pathology.

[2]  G. Frizzera,et al.  T‐Cell-Rich Large B‐Cell Lymphoma: A Study of 30 Cases, Supporting Its Histologic Heterogeneity and Lack of Clinical Distinctiveness , 1994, The American journal of surgical pathology.

[3]  Johannes Gerdes,et al.  Antigen unmasking on formalin‐fixed, paraffin‐embedded tissue sections , 1993, The Journal of pathology.

[4]  W. Pugh,et al.  T-cell-rich B-cell lymphoma. , 1993, Blood.

[5]  M. Colombo,et al.  Bone marrow stroma in humans: anti-nerve growth factor receptor antibodies selectively stain reticular cells in vivo and in vitro , 1993 .

[6]  Robert B. Shibuya,et al.  Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma. , 1993, The American journal of pathology.

[7]  M. Williams,et al.  T‐Cell-Rich B‐Cell Lymphomas: A Clinicopathologic Study of 19 Cases , 1992, The American journal of surgical pathology.

[8]  J. Delabie,et al.  Histiocyte‐Rich B‐Cell Lymphoma: A Distinct Clinicopathologic Entity Possibly Related to Lymphocyte Predominant Hodgkin's Disease, Paragranuloma Subtype , 1992, The American journal of surgical pathology.

[9]  P. Brousset,et al.  Large B‐cell lymphoma rich in T‐cells and simulating Hodgkin's disease , 1991, Histopathology.

[10]  G. Pinkus,et al.  Absence of bcl-2 major breakpoint region and JH gene rearrangement in lymphocyte predominance Hodgkin's disease. Results of Southern blot analysis and polymerase chain reaction. , 1991, The American journal of pathology.

[11]  J. Chan,et al.  Large B-cell lymphomas with a high content of reactive T cells. , 1989, Human pathology.

[12]  S. Pileri,et al.  BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. , 1989, Blood.

[13]  S. Poppema.  The nature of the lymphocytes surrounding Reed-Sternberg cells in nodular lymphocyte predominance and in other types of Hodgkin's disease. , 1989, The American journal of pathology.

[14]  G. Pinkus,et al.  Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker. , 1988, The American journal of pathology.

[15]  P. Isaacson,et al.  T‐Cell-Rich B‐Cell Lymphoma , 1988, The American journal of surgical pathology.

[16]  S. Poppema,et al.  Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[17]  S. Hsu,et al.  L&H variants of Reed-Sternberg cells express sialylated Leu M1 antigen. , 1986, The American journal of pathology.

[18]  H. Stein,et al.  An immunohistological study of the cellular constituents of Hodgkin's disease using a monoclonal antibody panel , 1984, Histopathology.

[19]  H. Stein,et al.  Production of a monoclonal antibody reactive with human dendritic reticulum cells and its use in the immunohistological analysis of lymphoid tissue. , 1983, Journal of clinical pathology.